13hon MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
10h
Eli Lilly’s New $299 Month-Long GLP‑1 Injector Shows Why It’s Winning the Weight‑Loss Race
Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...
The new KwikPen holds four weekly doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results